Too many people living with lung cancer still face delays, limited access, or barriers to getting the diagnostics and treatments they need. Lung Cancer Europe (LuCE) has launched the Access to Treatment Atlas – a major new advocacy tool designed to support efforts to improve equity across the continent.
As an active and full member of LuCE, FairLife Lung Cancer Care will promote the “Access to treatment Atlas” across Greece.
The Access to Treatment Atlas is an interactive online resource created with and for patient advocates and other stakeholders. It brings together information from over 30 European countries on the availability of licensed lung cancer treatments and diagnostics – including biomarker testing – and highlights how access differs between countries.
Users can explore the data through an interactive map, with filters by country, treatment, biomarker, cancer type, stage of disease and line of treatment.
“This Atlas is a response to what advocates across Europe have been saying for years – that where you live still too often determines the care you get,” said Debra Montague, President of Lung Cancer Europe. “We hope this tool gives advocates and organisations the evidence they need to push for better access, faster decisions, and ultimately, fairer treatment for everyone affected by lung cancer.”
The Atlas has been developed by Lung Cancer Europe in collaboration with external partners, including the European Federation of Pharmaceutical Industries and Associations (EFPIA), European Respiratory Society (ERS), European Lung Foundation (ELF), European Society for Medical Oncology (ESMO), European Thoracic Oncology Platform (ETOP), and From Testing to Targeted Treatments (FT3).
While the Atlas is designed primarily for patient advocates, it will also be useful for researchers, clinicians, policy-makers, and anyone working to improve access to lung cancer care.
Important notice: The information on this website is not intended for use within the UK.
Explore the Atlas: https://atlaslungcancereurope.eu
—
FAIRLIFE LUNG CANCER CARE
FairLife Lung Cancer Care (FairLife L.C.C.) founded in November 2020, is the first and only non-profit organization in Greece, exclusively dedicated to lung cancer, the leading cause of cancer-related death worldwide.
Our vision is to decrease mortality rates, improve survival rates, and enhance the quality of life for people impacted by lung cancer.
FairLife L.C.C.’s mission is to educate and raise awareness for lung cancer prevention while providing holistic support to patients and their families through information, guidance, and psychological support programs available nationwide. We advocate for universal access to information, early diagnosis, diagnostic tests, and innovative treatments without social exclusion.
To support our mission:
- we promote lung cancer prevention, early diagnosis and screening to decrease mortality rates.
- we raise awareness of the value of comprehensive molecular screening.
- we provide psychosocial support to patients, caregivers and family members.
- we encourage and educate patients, institutions and the general public about the value of clinical trials and access to new innovative therapies.
- we work to eliminate the lung cancer stigma, experienced by people, impacted by the disease.
- we educate the young generation and the wider public on the benefits of clean air for lung health.
- to this end, we engage them in environmental awareness and sustainability actions, advocating for a healthy environment with less pollution and less lung cancer.
FairLife L.C.C. has aligned its actions with the following Sustainable Development Goals (SDGs): Goal 3: Good Health and Wellbeing, Goal 10: Reduced Inequalities, Goal 13: Climate Action, Goal 17: Partnerships for the Goals.
The driving force behind the organization is Korina Pateli Bell, wife of Simon Bell, who lost his battle with lung cancer at the age of 57.
A key feature of our activities is the substantiated, extensive scientific information, obtained through collaboration with 25 national and international organizations and scientific relevant institutions, more than 85 distinguished Greek and international scientists.
FairLife L.C.C.’s activities are supported by more than 100 volunteers and 8 Brand Ambassadors.
4/6/2025
